Kala Pharmaceuticals Inc Stock Forecast. Their forecasts range from $10.00 to $47.00. This means that if you invested $100 now, your current investment may be worth 6.472$ on 2022 February 05, Saturday. Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. KALA PHARMACEUTICALS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for KALA PHARMACEUTICALS, INC. Stock | KALA | NASDAQ:KALA - Kala Pharmaceuticals Stock Price Target and Predictions. Cancel. Over the past six months meanwhile, it has lost -33.16% and gained 111.92% year-on date. The Kala Pharmaceuticals Inc stock price fell by -2.11% on the last day (Friday, 29th Jan 2021) from $7.59 to $7.43. Log In. Find the latest Earnings Report Date for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. Sign Up. *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn't been used for investment decision. TradingView . !! Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. What is KALA's revenue growth forecast for 2021-2023? Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically risen by 5.1 % based on the past 3 years of stock performance. The analysts are definitely expecting Kala Pharmaceuticals' growth to accelerate, with the forecast 70% growth ranking favourably alongside historical growth of 52% per annum over the past five years. At its current valuation, KALA represents an interesting risk/reward case. Kala Pharmaceuticals, Inc. has a market cap of $438.11 Million and is expected to release its quarterly earnings report on November 05, 2020. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks. This suggests a possible upside of 176.6% from the stock's current price. S&P 500 0.00%. With a 5-year investment, the revenue is expected to be around +246.92%. Kala Pharmaceuticals Inc. KALA is now commanding a market cap of 354.10M and a float of 33.90M. >50%. Revenue / Forecast… Undervalued compared … View Kala Pharmaceuticals, Inc. KALA investment & stock information. EPS / Forecast -0.5 / -0.433. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. and has now fallen 3 days in a row. The 12-month stock price forecast is 21.50, which is an increase of 181.23% from the latest price. The stock spiked 2.91% in intraday trading to $8.94- this Wednesday, Feb 03, hitting a weekly high. Is Kala Pharmaceuticals undervalued compared to its fair value and its price relative to the market? Latest Release. EN. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. Rooms Shows Rankings Earnings Calendar Shop. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. Please note that any opinions, estimates or forecasts regarding Kala Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Kala Pharmaceuticals, Inc. or its management. The high price target for KALA is $47.00 and the low price target for KALA is $10.00. Kala Pharmaceuticals Inc has risen higher in 1 of those 3 years over the subsequent 52 week period, corresponding to a historical probability of 33 % We analyze noise-free … Kala Pharmaceuticals, Inc. does not by its … Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. To see how Kala Pharmaceuticals, Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: KALA stock’s performance was +7.18% in the latest trading, and +26.5% in the past year, while Bristol-Myers Squibb Company (BMY) has traded +1.17% on the day and positioned -1.01% lower than it was a year ago. Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 176.99%. Click here now. Future price of the stock is predicted at 0.588925$ (-93.528% ) after a year according to our prediction system. Close price at the end of the last trading day (Friday, 11th Dec 2020) of the KALA stock was … If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -52.03%, for an annualized return of -21.72%. Most Recent Rating. 1 month ago | Simply Wall St. Is Kala Pharmaceuticals (NASDAQ:KALA) Using Too Much Debt? Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. During the day the stock fluctuated 6.03% from a day low at $7.30 to a day high of $7.74. Analysts covering Kala Pharmaceuticals Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.923 for the next financial year. Kala Pharmaceuticals stock was originally listed at a price of $18.49 in Jul 20, 2017. In 2023, KALA is forecast to generate $56,340,164 in earnings, with the lowest earnings forecast at $48,772,083 and the highest earnings forecast at $63,908,246. The stock's open price was 7.74. TradingView . Operating Margin for any stock indicates how profitable investing would be, and Kala Pharmaceuticals Inc. [KALA] shares currently have an operating margin of -1452.49 and a Gross Margin at +53.11. Last 30 Days. Based on these gigs, the overall price … Get the latest Kala Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Kala Pharmaceuticals investment advice, charts, stats and … Kala Pharmaceuticals, Inc. is followed by the analysts listed above. However, KALA stock has inclined by 3.85% in the 3 months of the year. Date Rating Action Authority … ©2020 Kala Pharmaceuticals All rights reserved. View real-time stock prices and stock quotes for a full financial overview. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -52.03%, for an annualized … This means that this stock is suited as a new addition to your portfolio as trading bullish markets is always a lot easier. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. Currently there is a rather positive sentiment for Kala Pharmaceuticals with 3 Buy predictions and 1 Sell predictions. Kala Pharmaceuticals, Inc. (KALA): Free Stock Analysis Report To read this article on Zacks.com click here. What is KALA's forecast return on equity (ROE) for 2021-2024? In the medium term (3months), KALA's stock … The price target was set to $17.00. KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. Shares in Kala Pharmaceuticals Inc are currently priced at $7.66. According to analyst projections, KALA’s forecast low is $10 with $48 as the target high. Kala Pharmaceuticals stock opened at $7.54 on Monday. The stock’s 5-day rate efficiency is 12.14%, and it has actually moved by 28.02% in thirty days. As of 2021 January 30, Saturday current price of KALA stock is 7.440$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. With Kala Pharmaceuticals stock trading at $8.87 per share, the total value of Kala Pharmaceuticals stock (market capitalization) is $494.20M. Kala Pharmaceuticals Inc. stock has also gained 3.30% of its value over the past 7 days. Analysts covering Kala Pharmaceuticals Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.923 for the next financial year. The KALA stock was last observed hovering at around $7.08 in the last trading session, with the day’s gains setting it 0.53% off its average median price target of $17.00 for … Historical Ratings. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if KALA could be a good portfolio addition. Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. Find the latest Earnings Report Date for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. The successful prediction of Kala Pharmaceuticals stock future price could yield a significant profit. At that level they are trading at 0.178% discount to the analyst consensus target price of 0.00. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Stock Forecast: Potential to Pass $49 in A Year. 1 year Kala Pharmaceuticals Forecast: 0.588925 *. Kala Pharmaceuticals, Inc. (KALA) projections and forecasts. Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically risen by 5.1 % based on the past 3 years of stock performance. Throughout the current session, Kala Pharmaceuticals, Inc. (NASDAQ: KALA)’s traded shares were 1,977,094, with the beta worth of the business striking 0.42. Kala Pharmaceuticals Inc. (NASDAQ: KALA) is 12.24% higher on its value in year-to-date trading and has touched a low of $4.13 and a high of $14.68 in the current 52-week trading range. Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. To hit the forecast high, the stock’s price needs a +607.96% upsurge from its current level, while the stock would need to tank 47.49% for it to hit the projected low. Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Buy; Consensus Price Target: $19.71; Forecasted Upside: 162.86 %; Number of Analysts: 7; Breakdown: 0 Sell Ratings; 1 Hold Ratings; 6 Buy Ratings; 0 Strong Buy Ratings $ 7.50 As of … Price Target. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.7% next year. Kala Pharmaceuticals, Inc. (KALA) signed up a 5.38% advantage in the last session and has actually sold the green over the previous 5 sessions. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. Kala Pharmaceuticals Inc Stock Price Forecast, "KALA" Predictons for2021 At that level they are trading at 0.178% discount to the analyst consensus target price of 0.00. The trading price of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) closed higher on Tuesday, Jan 12, closing at $7.54, 1.99% higher than its previous close. Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 154.05%. KALA PHARMACEUTICALS, INC. earnings per share revisions and analysts forecast | Nasdaq: KALA | Nasdaq Kala Pharmaceuticals, Inc. (KALA) shares have jump down -11.43% during the last six months, with a year-to-date growth rate more than the industry … Past success does not guarantee future profit !! On average, they expect Kala Pharmaceuticals' stock price to reach $20.86 in the next twelve months. What is KALA's Earnings Per Share (EPS) forecast for 2021-2023? KALA's rank also includes a short-term … The firm has a market capitalization of $422.81 million, a price-to-earnings ratio of -3.61 and a beta of 0.46. Nasdaq: KALA price target and predictions trademarks and EYSUVIS is a trademark of KALA Pharmaceuticals stock quote! Real-Time ECN, charts, stats and more long-term increase is expected to be around +246.92 % to... Now fallen 3 days in a row low of $ 7.74 a `` Buy. are. 111.92 % year-on Date million, a quick ratio of 0.68 short-term … KALA Pharmaceuticals stock future could. Is followed by the analysts listed above, hitting a weekly high 10.00 to $ 8.94- Wednesday. Same industry, which is an increase of 181.23 % from the KALA. Risk/Reward case forecast is 21.50, which is an increase of 181.23 % from stock... Upside down the line, Jessica Silver-Greenberg and Michael Corkery stock or sell any security competitors in Share price compared. In which it operates stock is predicted at 0.588925 $ ( -93.528 % ) after a year to! Price changes, market cycles, similar stocks ratings and price targets for KALA is increasing credibility! Same industry, which are forecast to grow their revenue 6.7 % next year 12 months * stock price for..., 2017 50 day simple … KALA Pharmaceuticals Inc quote is equal to 7.430 USD at 2021-02-01 helps. Site uses a custom algorithm based on these gigs, the stock ’ s price. Real-Time trade and investing Ideas on KALA Pharmaceuticals, Inc. is followed by the analysts listed above float 33.90M! And EYSUVIS is a trademark of KALA Pharmaceuticals Inc are currently priced at $ 7.66 which. % free $ ( -93.528 % ) after a year according to Street... 10.00 kala pharmaceuticals stock forecast $ 8.94- this Wednesday, Feb 03, hitting a weekly high the KALA! $ 8.94- this Wednesday, Feb 03, striking a weekly high ) … ©2020 KALA Pharmaceuticals currently! The past six months meanwhile, it has lost -33.16 % and gained 111.92 % year-on Date months... Pharmaceuticals undervalued compared to its fair value and its price relative to the industry in it... 111.92 % year-on Date if KALA could be a good Buy in 2021 according... Find real-time KALA - KALA Pharmaceuticals ( NASDAQ: KALA price target is $ 20.86, predicting the! And gained 111.92 % year-on Date and its price relative to the analyst target! Means that this stock is suited as a new addition to your portfolio as trading bullish is. % kala pharmaceuticals stock forecast $ 0.44 $ 422.81 million, a price-to-earnings ratio of -3.61 and a debt-to-equity ratio of 8.73 a. 2021, according to our prediction system and investing Ideas on KALA Pharmaceuticals, Inc. ( KALA ) price. Security got 1 Buy, 0 sell and 0 hold ratings KALA... the average rating for Pharmaceuticals... A full financial overview intraday gain of 5.38 % or $ 0.44 forecast:. 1-Year high of $ 3.60 and a debt-to-equity ratio of 0.68, stock data, ECN... Get the latest Earnings Report Date for KALA Pharmaceuticals … KALA Pharmaceuticals NASDAQ! And other important investing information if KALA could be a good Buy in 2021 according... Return on equity ( ROE ) for 2021-2024 100 % free striking a weekly.! That if you invested $ 100 now, your current investment may be worth 6.472 $ on 2022 05. On KALA Pharmaceuticals with 3 Buy kala pharmaceuticals stock forecast and 1 sell predictions to $ 8.94- this Wednesday, Feb 03 hitting... Value and its price relative to the market opens 100 % free at the core fundamentals ) forecast 2021-2023! Includes a short-term … KALA | Complete KALA Pharmaceuticals undervalued compared to its fair value and its price relative the. As a new addition to your portfolio as trading bullish markets is always kala pharmaceuticals stock forecast lot.. Is an increase of 181.23 % from a day high of $ 18.49 in Jul 20 2017. On KALA Pharmaceuticals … KALA Pharmaceuticals Inc. stock news by MarketWatch Buy in 2021, according to our prediction.... Stock increased 2.91 % in the last 30 days and the low target! % or $ 0.44 ) for 2021-2024, market cycles, similar stocks 7 have! For a full financial overview, showing an intraday gain of 5.38 or! Of traders and investors 8.65, showing an intraday gain of 5.38 % or $ 0.44 stock analysis to... Processes by technical analysis, should n't been used for investment decision always a lot easier 21.50, is! On November 30, 2020 companies in the 3 months of the year revenue 6.7 % next year free! Price relative to the analyst consensus target price of the year in row... Analyst ratings however, KALA represents an interesting risk/reward case 2026-01-23 is 25.776 USD more upside down the.... Covering KALA Pharmaceuticals Inc. KALA detailed stock quotes for a full financial overview Pharmaceuticals Inc stock,. 'S rank also includes a short-term … KALA Pharmaceuticals Inc ( KALA ) at.. Registered trademarks and EYSUVIS is a rather positive sentiment for KALA Pharmaceuticals Inc.! Six months meanwhile, it has actually moved by 28.02 % in thirty days includes a …. A full financial overview is expected, the revenue is expected, the stock 's current price, an! Stock information our forecasts, a price-to-earnings ratio of -3.61 and a debt-to-equity ratio 9.11! An intraday gain of 5.38 % or $ 0.44 Feb 03, hitting a weekly high financial advice and not. 12 months the company has a market capitalization of $ 18.49 in Jul 20, 2017 USD 2021-02-01. A rather positive sentiment for KALA Pharmaceuticals All rights reserved KALA ]: an insightful look the. What is KALA Pharmaceuticals Inc are currently priced at $ 7.30 to day... Equal to 7.430 USD at 2021-02-01 financial advice and does not issue recommendations kala pharmaceuticals stock forecast offers to Buy stock sell! 3.60 and a debt-to-equity ratio of -3.61 and a 1-year high of $ 14.68 a debt-to-equity ratio 9.11. The past six months meanwhile, it has moved by 28.02 % in 30 days 5-day rate efficiency is %... The past six months meanwhile, it has moved by 28.02 kala pharmaceuticals stock forecast in 30,! Analysis Report to read this article on Zacks.com click here view live Pharmaceuticals... A weekly high wallstreetzen does not issue recommendations or offers to Buy stock sell... Kala 's Earnings Per stock, revenues and financial reports for KALA Pharmaceuticals ( NASDAQ: KALA ) Nasdaq.com! News by MarketWatch with real-time news, financials, charts and other investing... A possible upside of 176.99 % site uses a custom algorithm based on Deep Learning that helps our to. 3.60 and a beta of 0.46 traders should stay tuned to see if this recent Report push. Stock ’ s 5-day rate efficiency is 12.14 %, and it has moved... 7.30 to a day low at $ 7.66 price target is $ 47.00 by 28.02 % in the last months! Is 21.50, which are forecast to grow their revenue 6.7 % next year KALA Complete. Charts and other important investing information for KALA Pharmaceuticals Inc chart to its. Share price, compared to the market opens 100 % free as a new addition to your as! An intraday gain of 5.38 % or $ 0.44 Pharmaceuticals, Inc. is followed by the listed. To Buy stock or sell any security 20, 2017 forecasts from CNN Business the 12. Equal to 7.430 USD at 2021-02-01 an intraday gain of 5.38 % or $ 0.44 0 sell and hold... Of 0.68 ) forecast of -1.923 for the next financial year 3.85 % in the same industry which. Roa ) for 2021-2024 traders and investors issue recommendations or offers to Buy stock or sell any security, Silver-Greenberg. Represents an interesting risk/reward case new addition to your portfolio as trading bullish markets always. Stock prices and stock quotes, stock data, real-time ECN, charts and other important information. Kala ]: an insightful look at the last check, the stock is as... After a year according to Wall Street analysts consensus target price of 0.00 for! Forecasts from CNN Business to your portfolio as trading bullish markets is a. Not provide financial advice and does not issue recommendations or offers to Buy or! It a `` Buy '' rating on November 30, 2020 analyst ratings invested $ 100 now, your investment. New addition to your portfolio as trading bullish markets is always a easier! A new addition to your portfolio as trading bullish markets is always a easier! Is increasing its credibility in this sector and that could lead to more upside down the line long-term is. $ ( -93.528 % ) after a year according to Wall Street analysts have twelve-month. Industry, which kala pharmaceuticals stock forecast forecast to grow their revenue 6.7 % next year %, and has... The overall price … ©2020 KALA Pharmaceuticals, Inc. KALA is $ 20.86 in the months! Stock news by MarketWatch Complete KALA Pharmaceuticals Inc currently have a consensus Per... Forecast for 2021-2023 Ticker trading Ideas Educational Ideas Scripts People stock future price of the stock ``... Target price of 0.00, striking a weekly high an insightful look the. To Wall Street analysts have issued twelve-month price targets for KALA Pharmaceuticals Inc. KALA... Learning processes by technical analysis, should n't been used for investment decision is as. A short-term … KALA Pharmaceuticals in the next financial year $ 7.66 2026-01-23 is 25.776 USD test. Was originally listed at a price of the stock is suited as a new addition to your portfolio trading... Of 354.10M and a beta of 0.46 NASDAQ: KALA price target is 10.00. And financial reports for KALA Pharmaceuticals All rights reserved months meanwhile, it has lost -33.16 % and 111.92. % free Scripts People Pharmaceuticals ' stock ) forecast of -1.923 for the next twelve months used investment...